TUBA1C and pancreatic ductal adenocarcinoma: Additionally, TUBA1C is upregulated in hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC), where it predicts poor prognosis and enhances cell proliferation and migration (67, 68).